Results 101 to 110 of about 27,605 (189)
Well‐Defined Nanostructures: Concept, Impact and Perspective
Small, EarlyView.This perspective explores a connectivity‐driven framework for classifying well‐defined nanostructures (WDNSs) beyond traditional dimensionality‐based approaches. By highlighting discrete connections, serial connections, 2.5D connections, and 3D interpenetrations, it examines the structural and functional impacts of WDNSs across catalysis, energy, and ...
Ningxiang Wu +3 more
wiley +1 more source
Small, EarlyView.The study combines in situ liquid transmission electron microscopy (TEM) imaging and correlative ex situ TEM analyses to investigate the nucleation, aggregation, and crystallization of the calcium‐phosphate (CaP) layer on titanium dioxide (TiO2) nanoparticle surfaces.
Jing Zhang +4 more
wiley +1 more source
Small Methods, EarlyView.A laser‐assisted strategy enables the in situ formation of whitlockite coatings on bone implants through a magnesium calcium phosphate intermediate. This approach overcomes synthesis barriers, yielding bioactive surfaces that promote bone–implant integration and vascularization, offering a scalable route for next‐generation regenerative implants ...
Daehyeok Kwon +14 more
wiley +1 more source
Clinical Oral Implants Research, EarlyView.ABSTRACT Objectives The aim of this study was to evaluate the effect of M101 gel in bone and peri‐implantitis healing and its safety of use. Materials and Methods M101 gel and solution (1 g/L) were evaluated in four different models: (i) human osteoblast culture; (ii) mouse calvarial defect; (iii) extraction model in dogs; (iv) peri‐implantitis model ...
Céline Stutz +12 more
wiley +1 more source
Clinical Oral Implants Research, EarlyView.ABSTRACT Objectives To assess the efficacy and safety of a cell‐based therapy for 3D bone augmentation of severe alveolar bone defects prior to dental implant placement. Materials and Methods A Phase 2 randomized controlled clinical trial evaluated the safety and efficacy of a cell therapy using expanded autologous iliac crest‐derived mesenchymal cells
Mariano Sanz +19 more
wiley +1 more source
Clinical Oral Implants Research, EarlyView.ABSTRACT Objective To assess clinical trends to prevent peri‐implantitis in applying a two‐step survey based on the Delphi method. Material and Methods A panel of participants aged < 45 years old selected by the Spanish Society of Periodontology (SEPA) was asked to answer a survey with 75 statements prepared by a steering committee.
Alberto Monje +12 more
wiley +1 more source
Clinical Oral Implants Research, EarlyView.ABSTRACT Background and Objectives Peri‐implantitis, a significant complication resulting from bacterial colonization on dental implants, presents a challenge in oral healthcare. Developing surfaces that inhibit bacterial adhesion while promoting tissue integration is crucial for improving implant outcomes.
Paula Nuevo +4 more
wiley +1 more source
Clinical Oral Implants Research, EarlyView.ABSTRACT Purpose To evaluate the short‐term success and survival rates of immediately restored surface modified two‐piece zirconia implants (CL). Material and Methods A total of 23 patients had received CL implants (n = 26) for single‐tooth replacements in the anterior and posterior maxilla and mandible at healed extraction sites.
G. Trimpou +5 more
wiley +1 more source
Role of Local Factors on the Occurrence of Peri‐Implantitis: A Cross‐Sectional Analysis
Clinical Oral Implants Research, EarlyView.ABSTRACT Objective A cross‐sectional study was made to evaluate the role of local factors, including surgical, implant, and prosthesis‐related parameters, in the presence of peri‐implantitis. Methods Consecutive partially edentulous patients with ≥ 1 implant presenting peri‐implantitis were included.
Alberto Monje +5 more
wiley +1 more source
Odanacatib Coating Supports Osseointegration of Implants: A Preclinical Study
Clinical Oral Implants Research, EarlyView.ABSTRACT Introduction Odanacatib (ODN), a cathepsin K inhibitor, is a drug that reduces bone resorption while preserving bone formation. ODN was initially developed for the treatment of postmenopausal osteoporosis, but further development as a systemic medication has been discontinued.
Natália dos Santos Sanches +10 more
wiley +1 more source